Your browser doesn't support javascript.
loading
Erythrophagocytosis is not a reproducible finding in liver biopsies, and is not associated with clinical diagnosis of hemophagocytic lymphohistiocytosis.
Desai, Niyati; Kudose, Satoru; Remotti, Helen E; Del Portillo, Armando; Fazlollahi, Ladan; Lee, Michael J; Xiong, Yuqing; Moreira, Roger K; Salomao, Marcela; Fiel, Maria Isabel; Gonzalez, Raul S; Misdraji, Joseph; Gill, Ryan M; Hart, John; Kleiner, David E; Drebber, Uta; Bellizzi, Andrew M; Lagana, Stephen M.
Afiliação
  • Desai N; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, 622 W 168th St.VC14-209A, New York, NY, 10032, USA.
  • Kudose S; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, 622 W 168th St.VC14-209A, New York, NY, 10032, USA.
  • Remotti HE; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, 622 W 168th St.VC14-209A, New York, NY, 10032, USA.
  • Del Portillo A; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, 622 W 168th St.VC14-209A, New York, NY, 10032, USA.
  • Fazlollahi L; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, 622 W 168th St.VC14-209A, New York, NY, 10032, USA.
  • Lee MJ; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, 622 W 168th St.VC14-209A, New York, NY, 10032, USA.
  • Xiong Y; Department of Pathology, Mass General Brigham, Boston, MA, USA.
  • Moreira RK; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Salomao M; Department of Pathology, Mayo Clinic, Scottsdale, AZ, USA.
  • Fiel MI; Department of Pathology, Mount Sinai School of Medicine, New York, NY, USA.
  • Gonzalez RS; Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, USA.
  • Misdraji J; Department of Pathology, Yale University, New Haven, USA.
  • Gill RM; Department of Pathology, University of California, San Francisco, San Francisco, USA.
  • Hart J; Department of Pathology, University of Chicago, Chicago, USA.
  • Kleiner DE; Laboratory of Pathology, National Cancer Institute, Bethesda, USA.
  • Drebber U; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
  • Bellizzi AM; Department of Pathology, University of Iowa, Iowa City, USA.
  • Lagana SM; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, 622 W 168th St.VC14-209A, New York, NY, 10032, USA. SML2179@cumc.columbia.edu.
Virchows Arch ; 484(1): 61-69, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37924345
ABSTRACT
Hemophagocytic lymphohistiocytosis (HLH) is a rare disease with high mortality. Liver involvement is common (based on elevated liver function tests) with most patients demonstrating acute hepatitis. Liver biopsies are frequently obtained in the setting of suspected HLH for the purpose of identification of erythrophagocytosis, and if present, this finding is thought to suggest or support the diagnosis of HLH. However, there are problems with this approach; in particular, we do not know whether this finding is reproducible or whether it is specific to HLH. Therefore, we conducted a multi-institutional study in which experienced liver pathologists reviewed images taken from liver biopsies from patients with normal liver, acute hepatitis, possible HLH, and clinical HLH to determine if there was agreement about the presence or absence of erythrophagocytosis, and to ascertain whether the finding corresponds to a clinical diagnosis of HLH. Twelve liver pathologists reviewed 141 images in isolation (i.e., no clinical information or diagnosis provided). These came from 32 patients (five normal, 17 acute hepatitis, six HLH, four possible HLH). The pathologists classified each image as negative, equivocal, or positive for erythrophagocytosis. Kappa was .08 (no agreement) for case-level and 0.1 for image-level (1.4% agreement, based on two images which were universally considered negative). There was no difference in the proportion of pathologists who diagnosed erythrophagocytosis among those with different diagnoses at case or image-level (p = 0.82 and p = 0.82, respectively). Thus, erythrophagocytosis is an entirely unreliable histologic parameter in liver, as it is irreproducible and not demonstrably associated with a clinical disease (namely, HLH). Unless and until more reliable guidelines can be established, pathologists should refrain from commenting on the presence or absence of erythrophagocytosis in liver biopsy.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfo-Histiocitose Hemofagocítica / Hepatite Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfo-Histiocitose Hemofagocítica / Hepatite Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article